AXOTROPIN 10 IU - Axio Labs

Before biotechnology reshaped hormone therapy, HGH was obtained from cadaver-sourced pituitary glands, a method both limited in supply and risky in safety. The turning point came in 1985, when the FDA banned cadaver-derived HGH due to links with Creutzfeldt-Jakob disease. That same year, Genentech’s somatrem became the first approved synthetic HGH. It was quickly replaced by somatropin, which perfectly mirrored the natural hormone’s structure and delivered improved therapeutic consistency.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about AXOTROPIN 10 IU by Axio Labs, consult with your doctor or healthcare professional.